Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases

Neuroscience and Biobehavioral Reviews

Volumn 64, Issue , 2016, Pages 134-147

  Garcia Bueno B ^a   Caso, J R ^a,b   Madrigal, J L M ^a   Leza, J C ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

Author keywords

Depression; Inflammation; Innate immunity; Schizophrenia; Stress; Toll like receptors

Indexed keywords

COCAINE; MYELOID DIFFERENTIATION FACTOR 88; OPIATE; RESATORVID; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4;

ALCOHOLISM; CENTRAL NERVOUS SYSTEM DISEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG ABUSE; DRUG MECHANISM; DRUG TARGETING; GENETIC MANIPULATION; HUMAN; MENTAL DISEASE; NERVOUS SYSTEM INFLAMMATION; NEUROTRANSMISSION; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STRESS; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; HUMANS; MENTAL DISORDERS; TOLL-LIKE RECEPTOR 4;

EID: 84959333739     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.02.013     Document Type: Review

References (184)

1. Abrahams V.M., Bole-Aldo P., Kim Y.M., Straszewski-Chavez S.L., Chaiworapongsa T., Romero R., Mor G. Divergent trophoblast responses to bacterial products mediated by TLRs. J. Immunol. 2004, 173:4286-4296.
2. Adachi J., Mizoi Y., Fukunaga T., Ogawa Y., Ueno Y., Imamichi H. Degrees of alcohol intoxication in 117 hospitalized cases. J. Stud. Alcohol 1991, 52:448-453.
3. Alfonso-Loeches S., Pascual-Lucas M., Blanco A.M., Sanchez-Vera I., Guerri C. Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J. Neurosci. 2010, 30:8285-8295.
4. Bajo M., Madamba S.G., Roberto M., Blednov Y.A., Sagi V.N., Roberts E., Rice K.C., Harris R.A., Siggins G.R. Innate immune factors modulate ethanol interaction with GABAergic transmission in mouse central amygdala. Brain Behav. Immun. 2014, 40:191-202.
5. Bates P.R., Hawkins A., Mahadik S.P., McGrath J.J. Heat stress lipids and schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 1996, 55:101-107.
6. Blanco A.M., Valles S.L., Pascual M., Guerri C. Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J. Immunol. 2005, 175:6893-6899.
7. Bornstein S.R., Schumann R.R., Rettori V., McCann S.M., Zacharowski K. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals. Horm. Metab. Res. 2004, 36:470-473.
8. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol 2002, 61:1013-1021.
9. Buchanan M.M., Hutchinson M., Watkins L.R., Yin H. Toll-like receptor 4 in CNS pathologies. J. Neurochem. 2010, 114:13-27.
10. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature 1996, 383:443-446.
11. Carty M., Bowie A.G. Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem. Pharmacol. 2011, 81:825-837.
12. Cassiani-Ingoni R., Cabral E.S., Lunemann J.D., Garza Z., Magnus T., Gelderblom H., Munson P.J., Marques A., Martin R. Borrelia burgdorferi Induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression. J. Neuropathol. Exp. Neurol. 2006, 65:540-548.
13. Chaniotou Z., Giannogonas P., Theoharis S., Teli T., Gay J., Savidge T., Koutmani Y., Brugni J., Kokkotou E., Pothoulakis C., Karalis K.P. Corticotropin-releasing factor regulates TLR4 expression in the colon and protects mice from colitis. Gastroenterology 2010, 139:2083-2092.
14. Chen G., Zhang S., Shi J., Ai J., Qi M., Hang C. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp. Neurol. 2009, 216:398-406.
15. Chuang T.H., Ulevitch R.J. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat. Immunol. 2004, 5:495-502.
16. Crews F.T., Qin L., Sheedy D., Vetreno R.P., Zou J. High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence. Biol. Psychiatry 2013, 73:602-612.
17. da Silva C.J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 2001, 276:21129-21135.
18. Dange R.B., Agarwal D., Masson G.S., Vila J., Wilson B., Nair A., Francis J. Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension. Cardiovasc. Res. 2014, 103:17-27.
19. Dange R.B., Agarwal D., Teruyama R., Francis J. Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension. J. Neuroinflammation 2015, 12:31.
20. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
21. De M.J., Yaddanapudi K., Hornig M., Villar G., Serge R., Lipkin W.I. Induction of Toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances. MBio 2010, 1.
22. Delaney J.R., Stoven S., Uvell H., Anderson K.V., Engstrom Y., Mlodzik M. Cooperative control of Drosophila immune responses by the JNK and NF-kappaB signaling pathways. EMBO J. 2006, 25:3068-3077.
23. Deleidi M., Hallett P.J., Koprich J.B., Chung C.Y., Isacson O. The Toll-like receptor-3 agonist polyinosinic: polycytidylic acid triggers nigrostriatal dopaminergic degeneration. J. Neurosci. 2010, 30:16091-16101.
24. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Leister F., Yang S., Krivogorsky B., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol. Psychiatry 2010, 68:100-104.
25. Divanovic S., Trompette A., Atabani S.F., Madan R., Golenbock D.T., Visintin A., Finberg R.W., Tarakhovsky A., Vogel S.N., Belkaid Y., Kurt-Jones E.A., Karp C.L. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 2005, 6:571-578.
26. Dong H., Zhang X., Dai X., Lu S., Gui B., Jin W., Zhang S., Zhang S., Qian Y. Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3 K/Akt/FoxO1 pathway. J. Neuroinflammation 2014, 11:140.
27. Du X., Fleiss B., Li H., D'angelo B., Sun Y., Zhu C., Hagberg H., Levy O., Mallard C., Wang X. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS One 2011, 6:e19583.
28. Eidson L.N., Murphy A.Z. Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine. J. Neurosci. 2013, 33:15952-15963.
29. Enstrom A.M., Onore C.E., Van de Water J.A., Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 2010, 24:64-71.
30. Fang P., Schachner M., Shen Y.Q. HMGB1 in development and diseases of the central nervous system. Mol. Neurobiol. 2012, 45:499-506.
31. Fernandez-Lizarbe S., Pascual M., Guerri C. Critical role of TLR4 response in the activation of microglia induced by ethanol. J. Immunol. 2009, 183:4733-4744.
32. Fleshner M. Stress-evoked sterile inflammation danger associated molecular patterns (DAMPs), microbial associated molecular patterns (MAMPs) and the inflammasome. Brain Behav. Immun. 2013, 27:1-7.
33. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 2003, 100:171-194.
34. Gárate I., García-Bueno B., Madrigal J.L., Bravo L., Berrocoso E., Caso J.R., Mico J.A., Leza J.C. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J. Neuroinflammation 2011, 8:151.
35. Gárate I., García-Bueno B., Madrigal J.L., Caso J.R., Alou L., Gomez-Lus M.L., Mico J.A., Leza J.C. Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol. Psychiatry 2013, 73:32-43.
36. Gárate I., García-Bueno B., Madrigal J.L., Caso J.R., Alou L., Gomez-Lus M.L., Leza J.C. Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. J. Neuroinflammation 2014, 11:8.
37. García-Bueno B., Bioque M., Mac-Dowell K.S., Barcones M.F., Martinez-Cengotitabengoa M., Pina-Camacho L., Rodriguez-Jimenez R., Saiz P.A., Castro C., Lafuente A., Santabarbara J., Gonzalez-Pinto A., Parellada M., Rubio G., Garcia-Portilla M.P., Mico J.A., Bernardo M., Leza J.C. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr. Bull. 2014, 40:376-387.
38. Glezer I., Zekki H., Scavone C., Rivest S. Modulation of the innate immune response by NMDA receptors has neuropathological consequences. J. Neurosci. 2003, 23:11094-11103.
39. Gorina R., Font-Nieves M., Marquez-Kisinousky L., Santalucia T., Planas A.M. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak1/Stat1 pathways. Glia 2011, 59:242-255.
40. Gosselin D., Rivest S. MyD88 signaling in brain endothelial cells is essential for the neuronal activity and glucocorticoid release during systemic inflammation. Mol. Psychiatry 2008, 13:480-497.
41. Grace P.M., Ramos K.M., Rodgers K.M., Wang X., Hutchinson M.R., Lewis M.T., Morgan K.N., Kroll J.L., Taylor F.R., Strand K.A., Zhang Y., Berkelhammer D., Huey M.G., Greene L.I., Cochran T.A., Yin H., Barth D.S., Johnson K.W., Rice K.C., Maier S.F., Watkins L.R. Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae. Neuroscience 2014, 280:299-317.
42. Grace P.M., Shimizu K., Strand K.A., Rice K.C., Deng G., Watkins L.R., Herson P.S. (+)-Naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitation. Brain Behav. Immunol. 2015.
43. Griffiths M.R., Gasque P., Neal J.W. The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review. Int. J. Inflam. 2010, 2010:151097.
44. Hajebrahimi B., Bagheri M., Hassanshahi G., Nazari M., Bidaki R., Khodadadi H., Arababadi M.K., Kennedy D. The adapter proteins of TLRs TRIF and MYD88, are upregulated in depressed individuals. Int. J. Psychiatry Clin. Pract. 2014, 18:41-44.
45. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., Eng J.K., Akira S., Underhill D.M., Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103.
46. Hayward J.H., Lee S.J. A decade of research on TLR2 discovering its pivotal role in glial activation and neuroinflammation in neurodegenerative diseases. Exp. Neurobiol. 2014, 23:138-147.
47. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
48. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002, 3:196-200.
49. Hines D.J., Choi H.B., Hines R.M., Phillips A.G., MacVicar B.A. Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLoS One 2013, 8:e60388.
50. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162:3749-3752.
51. Hu X., Yu Y., Eugene C.Y., Xia Q. The role of acetylation in TLR4-mediated innate immune responses. Immunol. Cell Biol. 2013, 91:611-614.
52. Hua F., Tang H., Wang J., Prunty M.C., Hua X., Sayeed I., Stein D.G. TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. J. Cereb. Blood Flow Metab. 2015, 35:536-542.
53. Huang M., Hu Y.Y., Dong X.Q., Xu Q.P., Yu W.H., Zhang Z.Y. The protective role of oxymatrine on neuronal cell apoptosis in the hemorrhagic rat brain. J. Ethnopharmacol. 2012, 143:228-235.
54. Hung Y.Y., Kang H.Y., Huang K.W., Huang T.L. Association between toll-like receptors expression and major depressive disorder. Psychiatry Res. 2014.
55. Hutchinson M.R., Ramos K.M., Loram L.C., Wieseler J., Sholar P.W., Kearney J.J., Lewis M.T., Crysdale N.Y., Zhang Y., Harrison J.A., Maier S.F., Rice K.C., Watkins L.R. Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats. Neuroscience 2009, 164:1821-1832.
56. Hutchinson M.R., Zhang Y., Shridhar M., Evans J.H., Buchanan M.M., Zhao T.X., Slivka P.F., Coats B.D., Rezvani N., Wieseler J., Hughes T.S., Landgraf K.E., Chan S., Fong S., Phipps S., Falke J.J., Leinwand L.A., Maier S.F., Yin H., Rice K.C., Watkins L.R. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav. Immun. 2010, 24:83-95.
57. Hutchinson M.R., Northcutt A.L., Hiranita T., Wang X., Lewis S.S., Thomas J., van S.K., Kopajtic T.A., Loram L.C., Sfregola C., Galer E., Miles N.E., Bland S.T., Amat J., Rozeske R.R., Maslanik T., Chapman T.R., Strand K.A., Fleshner M., Bachtell R.K., Somogyi A.A., Yin H., Katz J.L., Rice K.C., Maier S.F., Watkins L.R. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J. Neurosci. 2012, 32:11187-11200.
58. Hyun J., Kanagavelu S., Fukata M. A unique host defense pathway: TRIF mediates both antiviral and antibacterial immune responses. Microbes. Infect. 2013, 15:1-10.
59. Ishii K.J., Uematsu S., Akira S. 'Toll' gates for future immunotherapy. Curr. Pharm. Des. 2006, 12:4135-4142.
60. Jiang W., Gilkeson G. Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE). J. Immunother. Appl. 2014, 1:1.
61. Jou I., Lee J.H., Park S.Y., Yoon H.J., Joe E.H., Park E.J. Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am. J. Pathol 2006, 168:1619-1630.
62. Keri S., Szabo C., Kelemen O. Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain Behav. Immun. 2014, 40:235-243.
63. Kigerl K.A., Lai W., Rivest S., Hart R.P., Satoskar A.R., Popovich P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 2007, 102:37-50.
64. Kizaki T., Izawa T., Sakurai T., Haga S., Taniguchi N., Tajiri H., Watanabe K., Day N.K., Toba K., Ohno H. Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2. Immunology 2008, 124:348-356.
65. Kuang X., Wang L.F., Yu L., Li Y.J., Wang Y.N., He Q., Chen C., Du J.R. Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling. Free Radic. Biol. Med 2014, 71:165-175.
66. Lacroix S., Feinstein D., Rivest S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol. 1998, 8:625-640.
67. Laflamme N., Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 2001, 15:155-163.
68. Lafon M., Megret F., Lafage M., Prehaud C. The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J. Mol. Neurosci. 2006, 29:185-194.
69. Laird M.D., Shields J.S., Sukumari-Ramesh S., Kimbler D.E., Fessler R.D., Shakir B., Youssef P., Yanasak N., Vender J.R., Dhandapani K.M. High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia 2014, 62:26-38.
70. Leclercq S., Cani P.D., Neyrinck A.M., Starkel P., Jamar F., Mikolajczak M., Delzenne N.M., de T.P. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects. Brain Behav. Immun 2012, 26:911-918.
71. Lee K.M., Kim J.M., Baik E.J., Ryu J.H., Lee S.H. Isobavachalcone attenuates lipopolysaccharide-induced ICAM-1 expression in brain endothelial cells through blockade of toll-like receptor 4 signaling pathways. Eur. J. Pharmacol 2015, 754:11-18.
72. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8514-8519.
73. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012, 36:764-785.
74. Leow-Dyke S., Allen C., Denes A., Nilsson O., Maysami S., Bowie A.G., Rothwell N.J., Pinteaux E. Neuronal Toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J. Neuroinflammation 2012, 9:230.
75. Levy J. The effects of antibiotic use on gastrointestinal function. Am. J. Gastroenterol. 2000, 95:S8-10.
76. Lewis S.S., Loram L.C., Hutchinson M.R., Li C.M., Zhang Y., Maier S.F., Huang Y., Rice K.C., Watkins L.R. (+)-naloxone an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats. J. Pain 2012, 13:498-506.
77. Leza J.C., García-Bueno B., Bioque M., Arango C., Parellada M., Do K., O'Donnell P., Bernardo M. Inflammation in schizophrenia: a question of balance. Neurosci. Biobehav. Rev. 2015, 55:612-626.
78. Li X.Q., Wang J., Fang B., Tan W.F., Ma H. Intrathecal antagonism of microglial TLR4 reduces inflammatory damage to blood-spinal cord barrier following ischemia/reperfusion injury in rats. Mol. Brain 2014, 7:28.
79. Liu J., Yang A.R., Kelly T., Puche A., Esoga C., June H.L., Elnabawi A., Merchenthaler I., Sieghart W., June H.L., Aurelian L. Binge alcohol drinking is associated with GABAA alpha2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4465-4470.
80. Liu J., Buisman-Pijlman F., Hutchinson M.R. Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder. Front Neurosci. 2014, 8:309.
81. Loiarro M., Sette C., Gallo G., Ciacci A., Fanto N., Mastroianni D., Carminati P., Ruggiero V. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-B. J. Biol. Chem. 2005, 280:15809-15814.
82. Lu S.M., Gui B., Dong H.Q., Zhang X., Zhang S.S., Hu L.Q., Liu H.L., Sun J., Qian Y.N. Prophylactic lithium alleviates splenectomy-induced cognitive dysfunction possibly by inhibiting hippocampal TLR4 activation in aged rats. Brain Res. Bull. 2015, 114:31-41.
83. Ma Y., Li J., Chiu I., Wang Y., Sloane J.A., Lu J., Kosaras B., Sidman R.L., Volpe J.J., Vartanian T. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 2006, 175:209-215.
84. Ma Y., Haynes R.L., Sidman R.L., Vartanian T. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle 2007, 6:2859-2868.
85. MacDowell K.S., Caso J.R., Martin-Hernandez D., Madrigal J.I., Leza J.C., Garcia-Bueno B. Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress. Int. J. Neuropsychopharmacol. 2015, 18.
86. Maes M., Leunis J.C. Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuro. Endocrinol. Lett. 2008, 29:902-910.
87. Maes M., Kubera M., Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro. Endocrinol. Lett 2008, 29:117-124.
88. Maes M., Galecki P., Verkerk R., Rief W. Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity. Neuro. Endocrinol. Lett. 2011, 32:264-273.
89. Maes M., Kubera M., Leunis J.C., Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 2012, 141:55-62.
90. Mandrekar P., Dolganiuc A., Bellerose G., Kodys K., Romics L., Nizamani R., Szabo G. Acute alcohol inhibits the induction of nuclear regulatory factor kappa B activation through CD14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory kappa B alpha degradation?. Alcohol Clin. Exp. Res. 2002, 26:1609-1614.
91. Marta M. Toll-like receptors in multiple sclerosis mouse experimental models. Ann. N. Y. Acad. Sci. 2009, 1173:458-462.
92. Martinez C.C., Astort F., Di Gruccio J.M., Repetto E.M., Mercau M., Giordanino E., Sanchez R., Pignataro O., Arias P., Cymeryng C.B. Lipopolysaccharide stimulates adrenal steroidogenesis in rodent cells by a NFkappaB-dependent mechanism involving COX-2 activation. Mol. Cell Endocrinol. 2011, 337:1-6.
93. Matsunaga N., Tsuchimori N., Matsumoto T., Ii M. TAK-242 (resatorvid) a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol. Pharmacol. 2011, 79:34-41.
94. McCusker R.H., Kelley K.W. Immune-neural connections: how the immune system's response to infectious agents influences behavior. J. Exp. Biol. 2013, 216:84-98.
95. McKernan D.P., Dennison U., Gaszner G., Cryan J.F., Dinan T.G. Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl. Psychiatry 2011, 1:e36.
96. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
97. Meyer U., Schwarz M.J., Muller N. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol. Ther. 2011, 132:96-110.
98. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 1993, 60:1650-1657.
99. Mollen K.P., Anand R.J., Tsung A., Prince J.M., Levy R.M., Billiar T.R. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006, 26:430-437.
100. Monroe S.M., Simons A.D. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychol. Bull. 1991, 110:406-425.
101. Moraga A., Pradillo J.M., Cuartero M.I., Hernandez-Jimenez M., Oses M., Moro M.A., Lizasoain I. Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia. FASEB J. 2014.
102. Muller N., Wagner J.K., Krause D., Weidinger E., Wildenauer A., Obermeier M., Dehning S., Gruber R., Schwarz M.J. Impaired monocyte activation in schizophrenia. Psychiatry Res. 2012, 198:341-346.
103. Myint A.M., Kim Y.K., Verkerk R., Scharpe S., Steinbusch H., Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J. Affect. Disord. 2007, 98:143-151.
104. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 2002, 3:667-672.
105. Nagyoszi P., Wilhelm I., Farkas A.E., Fazakas C., Dung N.T., Hasko J., Krizbai I.A. Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochem. Int. 2010, 57:556-564.
106. Nicotra L., Loram L.C., Watkins L.R., Hutchinson M.R. Toll-like receptors in chronic pain. Exp. Neurol. 2012, 234:316-329.
107. Nijs J., Nees A., Paul L., De K.M., Ickmans K., Meeus M., van O.J. Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review. Exerc. Immunol. Rev. 2014, 20:94-116.
108. Noreen M., Shah M.A., Mall S.M., Choudhary S., Hussain T., Ahmed I., Jalil S.F., Raza M.I. TLR4 polymorphisms and disease susceptibility. Inflamm. Res. 2012, 61:177-188.
109. Northcutt A.L., Hutchinson M.R., Wang X., Baratta M.V., Hiranita T., Cochran T.A., Pomrenze M.B., Galer E.L., Kopajtic T.A., Li C.M., Amat J., Larson G., Cooper D.C., Huang Y., O'Neill C.E., Yin H., Zahniser N.R., Katz J.L., Rice K.C., Maier S.F., Bachtell R.K., Watkins L.R. DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. Mol. Psychiatry 2015.
110. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14:511-522.
111. Oak S., Mandrekar P., Catalano D., Kodys K., Szabo G. J. Immunol. 2006, 176:7628-7635.
112. Obata K., Katsura H., Miyoshi K., Kondo T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Akira S., Noguchi K. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J. Neurochem. 2008, 105:2249-2259.
113. Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011, 34:269-281.
114. Oliveira J., Busson M., Etain B., Jamain S., Hamdani N., Boukouaci W., Amokrane K., Bennabi M., Le G.E., Dargel A.A., Houenou J., Ivanova R., Bellivier F., Henry C., Kahn J.P., Charron D., Krishnamoorthy R., Vervoitte L., Leboyer M., Tamouza R. Polymorphism of Toll-like receptor 4 gene in bipolar disorder. J. Affect. Disord. 2014, 152-154:395-402.
115. Oosting M., Cheng S.C., Bolscher J.M., Vestering-Stenger R., Plantinga T.S., Verschueren I.C., Arts P., Garritsen A., van E.H., Sturm P., Kullberg B.J., Hoischen A., Adema G.J., van der Meer J.W., Netea M.G., Joosten L.A. Human TLR10 is an anti-inflammatory pattern-recognition receptor. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E4478-E4484.
116. Pandey G.N., Rizavi H.S., Ren X., Bhaumik R., Dwivedi Y. Toll-like receptors in the depressed and suicide brain. J. Psychiatry Res. 2014, 53:62-68.
117. Pascual M., Balino P., Alfonso-Loeches S., Aragon C.M., Guerri C. Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain Behav. Immun. 2011, 25(Suppl 1):S80-S91.
118. Pedrazzi M., Averna M., Sparatore B., Patrone M., Salamino F., Marcoli M., Maura G., Cervetto C., Frattaroli D., Pontremoli S., Melloni E. Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein. PLoS One 2012, 7:e44518.
119. Peri F., Piazza M. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Biotechnol. Adv. 2012, 30:251-260.
120. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediators. Inflammt. 2010, 2010.
121. Pla A., Pascual M., Renau-Piqueras J., Guerri C. TLR4 mediates the impairment of ubiquitin-proteasome and autophagy-lysosome pathways induced by ethanol treatment in brain. Cell Death Dis. 2014, 5:e1066.
122. Plotnikov A., Zehorai E., Procaccia S., Seger R. The MAPK cascades: signaling components: nuclear roles and mechanisms of nuclear translocation. Biochim. Biophys. Acta 2011, 1813:1619-1633.
123. Poltorak A., He X., Smirnova I., Liu M.Y., Van H.C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/He: J and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
124. Poltorak A., Smirnova I., He X., Liu M.Y., Van H.C., McNally O., Birdwell D., Alejos E., Silva M., Du X., Thompson P., Chan E.K., Ledesma J., Roe B., Clifton S., Vogel S.N., Beutler B. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 1998, 24:340-355.
125. Qiao H., Zhang X., Zhu C., Dong L., Wang L., Zhang X., Xing Y., Wang C., Ji Y., Cao X. Luteolin downregulates TLR4, TLR5, NF-kappaB and p-p38MAPK expression upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Res. 2012, 1448:71-81.
126. Qin X., Sun Z.Q., Dai X.J., Mao S.S., Zhang J.L., Jia M.X., Zhang Y.M. Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation. Neurol. Res. 2012, 34:379-389.
127. Qin X., Sun Z.Q., Zhang X.W., Dai X.J., Mao S.S., Zhang Y.M. TLR4 signaling is involved in the protective effect of propofol in BV2 microglia against OGD/reoxygenation. J. Physiol. Biochem. 2013, 69:707-718.
128. Qiu J., Nishimura M., Wang Y., Sims J.R., Qiu S., Savitz S.I., Salomone S., Moskowitz M.A. Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:927-938.
129. Rajbhandari L., Tegenge M.A., Shrestha S., Ganesh K.N., Malik A., Mithal A., Hosmane S., Venkatesan A. Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons. Glia 2014.
130. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 2007, 9:1081-1088.
131. Romanovsky A.A., Steiner A.A., Matsumura K. Cells that trigger fever. Cell Cycle 2006, 5:2195-2197.
132. Sarvestani S.T., Williams B.R., Gantier M.P. Human Toll-like receptor 8 can be cool too: implications for foreign RNA sensing. J. Interferon Cytokine Res. 2012, 32:350-361.
133. Sauer R.S., Hackel D., Morschel L., Sahlbach H., Wang Y., Mousa S.A., Roewer N., Brack A., Rittner H.L. Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation. Mol. Pain 2014, 10:10.
134. Savitz J., Drevets W.C., Wurfel B.E., Ford B.N., Bellgowan P.S., Victor T.A., Bodurka J., Teague T.K., Dantzer R. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav. Immun. 2015, 46:55-59.
135. Seok S.M., Park T.Y., Park H.S., Baik E.J., Lee S.H. Fructose-1,6-bisphosphate suppresses lipopolysaccharide-induced expression of ICAM-1 through modulation of toll-like receptor-4 signaling in brain endothelial cells. Int. Immunopharmacol. 2015, 26:203-211.
136. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4:469-478.
137. Severance E.G., Gressitt K.L., Stallings C.R., Origoni A.E., Khushalani S., Leweke F.M., Dickerson F.B., Yolken R.H. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr. Res. 2013, 148:130-137.
138. Severance E.G., Yolken R.H., Eaton W.W. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr. Res. 2014.
139. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2: a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999, 189:1777-1782.
140. Stefanova N., Reindl M., Neumann M., Kahle P.J., Poewe W., Wenning G.K. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov. Disord. 2007, 22:2196-2203.
141. Strekalova T., Evans M., Costa-Nunes J., Bachurin S., Yeritsyan N., Couch Y., Steinbusch H.M., Eleonore K.S., Lesch K.P., Anthony D.C. Tlr4 upregulation in the brain accompanies depression- and anxiety-like behaviors induced by a high-cholesterol diet. Brain Behav. Immun. 2015.
142. Sun X., Ji C., Hu T., Wang Z., Chen G. Tamoxifen as an effective neuroprotectant against early brain injury and learning deficits induced by subarachnoid hemorrhage: possible involvement of inflammatory signaling. J. Neuroinflammation 2013, 10:157.
143. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129:3006-3019.
144. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
145. Takeuchi O., Kawai T., Sanjo H., Copeland N.G., Gilbert D.J., Jenkins N.A., Takeda K., Akira S. TLR6: a novel member of an expanding toll-like receptor family. Gene 1999, 231:59-65.
146. Tang S.C., Lathia J.D., Selvaraj P.K., Jo D.G., Mughal M.R., Cheng A., Siler D.A., Markesbery W.R., Arumugam T.V., Mattson M.P. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 2008, 213:114-121.
147. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci. 2001, 26:167-174.
148. Tobias P.S., Soldau K., Gegner J.A., Mintz D., Ulevitch R.J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 1995, 270:10482-10488.
149. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 2002, 115:2603-2611.
150. Trotta T., Porro C., Calvello R., Panaro M.A. Biological role of Toll-like receptor-4 in the brain. J. Neuroimmunol. 2014, 268:1-12.
151. Uesugi T., Froh M., Arteel G.E., Bradford B.U., Thurman R.G. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001, 34:101-108.
152. Vakharia K., Hinson J.P. Lipopolysaccharide directly stimulates cortisol secretion by human adrenal cells by a cyclooxygenase-dependent mechanism. Endocrinology 2005, 146:1398-1402.
153. Valles S.L., Blanco A.M., Pascual M., Guerri C. Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes. Brain Pathol. 2004, 14:365-371.
154. Venkatasubramanian G., Debnath M. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 44:301-311.
155. Vetreno R.P., Crews F.T. Adolescent binge drinking increases expression of the danger signal receptor agonist HMGB1 and Toll-like receptors in the adult prefrontal cortex. Neuroscience 2012, 226:475-488.
156. Vetreno R.P., Yaxley R., Paniagua B., Crews F.T. Diffusion tensor imaging reveals adolescent binge ethanol-induced brain structural integrity alterations in adult rats that correlate with behavioral dysfunction. Addict. Biol. 2015.
157. Wang Z., Zuo G., Shi X.Y., Zhang J., Fang Q., Chen G. Progesterone administration modulates cortical TLR4/NF-kappaB signaling pathway after subarachnoid hemorrhage in male rats. Mediators. Inflamm. 2011, 2011:848309.
158. Wang M., Wang Y., He J., Wei S., Zhang N., Liu F., Liu X., Kang Y., Yao X. Albumin induces neuroprotection against ischemic stroke by altering Toll-like receptor 4 and regulatory T cells in mice. CNS Neurol. Disord. Drug Targets 2013, 12:220-227.
159. Wang Y.C., Wang P.F., Fang H., Chen J., Xiong X.Y., Yang Q.W. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 2013, 44:2545-2552.
160. Wang C.P., Li J.L., Zhang L.Z., Zhang X.C., Yu S., Liang X.M., Ding F., Wang Z.W. Isoquercetin protects cortical neurons from oxygen-glucose deprivation-reperfusion induced injury via suppression of TLR4-NF-small ka, CyrillicB signal pathway. Neurochem. Int. 2013, 63:741-749.
161. Wang Z., Wu L., You W., Ji C., Chen G. Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway. J. Pineal Res. 2013, 55:399-408.
162. Wang L., Li Z., Zhang X., Wang S., Zhu C., Miao J., Chen L., Cui L., Qiao, H Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-kappaB, TNF-alpha and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability. Neurochem. Res. 2014, 39:97-106.
163. Wang P.F., Fang H., Chen J., Lin S., Liu Y., Xiong X.Y., Wang Y.C., Xiong R.P., Lv F.L., Wang J., Yang Q.W. Polyinosinic-polycytidylic acid has therapeutic effects against cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via TLR3. J. Immunol. 2014, 192:4783-4794.
164. Wang X., Wang C., Wang J., Zhao S., Zhang K., Wang J., Zhang W., Wu C., Yang J. Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-kappaB, MAPKs and Akt signaling pathways. Neuropharmacology 2014, 79:642-656.
165. Wang C.X., Xie G.B., Zhou C.H., Zhang X.S., Li T., Xu J.G., Li N., Ding K., Hang C.H., Shi J.X., Zhou M.L. Baincalein alleviates early brain injury after experimental subarachnoid hemorrhage in rats: possible involvement of TLR4/NF-kappaB-mediated inflammatory pathway. Brain Res. 2015, 1594:245-255.
166. Watkins L.R., Hutchinson M.R., Rice K.C., Maier S.F. The toll of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol. Sci. 2009, 30:581-591.
167. Weber M.D., Frank M.G., Sobesky J.L., Watkins L.R., Maier S.F. Blocking toll-like receptor 2 and 4 signaling during a stressor prevents stress-induced priming of neuroinflammatory responses to a subsequent immune challenge. Brain Behav. Immun. 2013, 32:112-121.
168. Wu F.X., Bian J.J., Miao X.R., Huang S.D., Xu X.W., Gong D.J., Sun Y.M., Lu Z.J., Yu W.F. Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain. Int. J. Med. Sci. 2010, 7:251-259.
169. Wu Y., Lousberg E.L., Moldenhauer L.M., Hayball J.D., Coller J.K., Rice K.C., Watkins L.R., Somogyi A.A., Hutchinson M.R. Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in mice. Br. J. Pharmacol. 2012, 165:1319-1329.
170. Xia M.X., Ding X., Qi J., Gu J., Hu G., Sun X.L. Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain. J. Neuroimmunol. 2014, 273:53-57.
171. Xiang H.F., Cao D.H., Yang Y.Q., Wang H.Q., Zhu L.J., Ruan B.H., Du J., Wang M.C. Isoflurane protects against injury caused by deprivation of oxygen and glucose in microglia through regulation of the Toll-like receptor 4 pathway. J. Mol. Neurosci. 2014, 54:664-670.
172. Yan X., Jiang E., Weng H.R. Activation of toll like receptor 4 attenuates GABA synthesis and postsynaptic GABA receptor activities in the spinal dorsal horn via releasing interleukin-1 beta. J. Neuroinflammation 2015, 12:222.
173. Yao L., Kan E.M., Lu J., Hao A., Dheen S.T., Kaur C., Ling E.A. Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. J. Neuroinflammation 2013, 10:23.
174. Ye Y., Xu H., Zhang X., Li Z., Jia Y., He X., Huang J.H. Association between toll-like receptor 4 expression and neural stem cell proliferation in the hippocampus following traumatic brain injury in mice. Int. J. Mol. Sci. 2014, 15:12651-12664.
175. Yu W.H., Dong X.Q., Hu Y.Y., Huang M., Zhang Z.Y. Ginkgolide B reduces neuronal cell apoptosis in the traumatic rat brain: possible involvement of toll-like receptor 4 and nuclear factor kappa B pathway. Phytother. Res. 2012, 26:1838-1844.
176. Zacharowski K., Zacharowski P.A., Koch A., Baban A., Tran N., Berkels R., Papewalis C., Schulze-Osthoff K., Knuefermann P., Zahringer U., Schumann R.R., Rettori V., McCann S.M., Bornstein S.R. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6392-6397.
177. Zeng K.W., Zhang T., Fu H., Liu G.X., Wang X.M. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-kappaB signaling pathway in lipopolysaccharide-induced microglia. Eur. J. Pharmacol. 2012, 692:29-37.
178. Zhang D., Li H., Li T., Zhou M., Hao S., Yan H., Yu Z., Li W., Li K., Hang C. TLR4 inhibitor resatorvid provides neuroprotection in experimental traumatic brain injury: implication in the treatment of human brain injury. Neurochem. Int. 2014, 75:11-18.
179. Zhang J., Fu B., Zhang X., Zhang L., Bai X., Zhao X., Chen L., Cui L., Zhu C., Wang L., Zhao Y., Zhao T., Wang X. Bicyclol upregulates transcription factor Nrf2: HO-1 expression and protects rat brains against focal ischemia. Brain Res. Bull. 2014, 100:38-43.
180. Zhang J., Wu Y., Weng Z., Zhou T., Feng T., Lin Y. Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway. Brain Res. 2014, 1582:176-186.
181. Zhang T., Su J., Guo B., Zhu T., Wang K., Li X. Ursolic acid alleviates early brain injury after experimental subarachnoid hemorrhage by suppressing TLR4-mediated inflammatory pathway. Int. Immunopharmacol. 2014, 23:585-591.
182. Zhang L., Li Y.J., Wu X.Y., Hong Z., Wei W.S. MicroRNA-181c negatively regulates the inflammatory response in oxygen-glucose-deprived microglia by targeting Toll-like receptor 4. J. Neurochem. 2015, 132:713-723.
183. Zhao A.P., Dong Y.F., Liu W., Gu J., Sun X.L. Nicorandil inhibits inflammasome activation and Toll-like receptor-4 signal transduction to protect against oxygen-glucose deprivation-induced inflammation in BV-2 cells. CNS. Neurosci. Ther. 2014, 20:147-153.
184. Zhu H.T., Bian C., Yuan J.C., Chu W.H., Xiang X., Chen F., Wang C.S., Feng H., Lin J.K. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-kappaB signaling pathway in experimental traumatic brain injury. J. Neuroinflammation 2014, 11:59.